Gsk (GSK) Equity Income (2009 - 2021)
Gsk (GSK) posted quarterly Equity Income of $44.5 million for Q4 2021, up 661.48% year-over-year from $5.8 million in Q4 2020, and up 661.48% quarter-over-quarter from -$7.9 million in Q4 2020.
Gsk (GSK) Equity Income (2009 - 2021) Analysis & Trends
Gsk's Equity Income history runs 11 years deep, the most recent figure standing at $44.5 million for Q4 2021.
- In Q4 2021, Equity Income rose 661.48% year-over-year to $44.5 million; the TTM figure through Dec 2021 stood at $95.6 million (down 34.64% YoY), while the FY2018 annual figure was $37.4 million, up 81.43% from the prior year.
- Equity Income for Q4 2021 stood at $44.5 million, up from -$7.9 million in the prior quarter.
- The five-year high for Equity Income was $95.1 million in Q4 2019, with the low at -$7.9 million in Q4 2020.
- The 4-year median for Equity Income is $14.5 million (2020), against an average of $23.7 million.
- The sharpest annual moves came in 2020 and 2021: Equity Income tumbled 108.33% in 2020, then surged 661.48% in 2021.
- Gsk's Equity Income stood at $5.3 million in 2017, then surged by 1691.56% to $95.1 million in 2019, then slumped by 108.33% to -$7.9 million in 2020, then jumped by 661.48% to $44.5 million in 2021.
- Business Quant data shows GSK's Equity Income at $44.5 million in Q4 2021, -$7.9 million in Q4 2020, and $35.4 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | - |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -10.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -4.03 Mn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | -10.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 44.48 Mn |
| Dec 31, 2020 | -7.92 Mn |
| Sep 28, 2020 | 35.45 Mn |
| Jun 30, 2020 | 23.59 Mn |
| Dec 31, 2019 | 95.14 Mn |
| Jun 30, 2019 | -5.15 Mn |
| Dec 31, 2017 | 5.31 Mn |
| Jun 30, 2017 | -1.28 Mn |
| Dec 31, 2016 | -2.49 Mn |
| Sep 30, 2016 | 7.89 Mn |
| Dec 31, 2015 | 21.24 Mn |
| Sep 30, 2015 | -3.10 Mn |
| Dec 31, 2014 | 47.53 Mn |
| Dec 31, 2013 | -1.62 Mn |
| Dec 31, 2012 | 16.06 Mn |
| Dec 31, 2011 | -7.86 Mn |
| Sep 30, 2011 | -3.22 Mn |
| Mar 31, 2009 | -20.12 Mn |